Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001005477-08-001245
Filing Date
2008-02-12
Accepted
2008-02-12 17:27:45
Documents
1
Group Members
NEUBERGER BERMAN EQUITY FUNDSNEUBERGER BERMAN MANAGEMENT INC.NEUBERGER BERMAN, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NUMBER 8 TO SCHEDULE 13G file001.txt SC 13G/A 17943
  Complete submission text file 0001005477-08-001245.txt   20160
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Subject) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-41682 | Film No.: 08599690
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 605 THIRD AVE NEW YORK NY 10158
Business Address 605 THIRD AVE NEW YORK NY 10158 2124764654
NEUBERGER BERMAN INC (Filed by) CIK: 0001068144 (see all company filings)

EIN.: 061523639 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice